Transcription of EudraVigilance - EVWEB User Manual
{{id}} {{{paragraph}}}
30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website European Medicines Agency, 2022. Reproduction is authorised provided the source is acknowledged. 14 March 2021 EMA/501718/2018 Data Analytics and Methods Task Force EudraVigilance - EVWEB user Manual Version corr. EudraVigilance - EVWEB user Manual EMA/501718/2018 Page 2/104 Summary of changes: Section Figure 132 and Table updated EudraVigilance - EVWEB user Manual EMA/501718/2018 Page 3/104 Table of Contents Table of Contents .. 3 1. Introduction .. 5 About this user Manual .. 5 Typographical Conventions .. 5 EudraVigilance (EV) .. 5 Main Functional Components of EudraVigilance .. 6 EudraVigilance Database Management System (EVDBMS).
presentation during all phases of the drug regulatory process (i.e. the pre- and post-authorisation phase). These processes include clinical studies, reports of spontaneous adverse reactions, events, regulatory submissions and regulated product …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}